Op-Eds Same treatment, 30% less pay: Medicare’s new math will put cancer care out of reach Shannon MacDonald · September 27, 2026 10:00 am
Op-Eds An Olympic champion’s $70,000 IVF nightmare proves why TrumpRx is a game-changer Monique Yohanan · September 25, 2026 9:00 am
Fairness and Justice Medicare’s new fraud strategy is a model for program integrity Vladlena Klymova · September 25, 2026 12:00 am
Op-Eds A simple blood test could catch cancer early. Washington won’t let you have it Eric Wargotz · September 24, 2026 11:00 am
Op-Eds Delay is a death sentence. Why rare disease families don’t trust Trump’s FDA nominee Shahriar Minokadeh · September 24, 2026 10:36 am
Op-Eds One visit, two bills: How Medicare is quietly fleecing America’s seniors Saul Anuzis · September 24, 2026 10:00 am
Fairness and Justice The 340B debate can’t ignore supply chain realities Tomas Philipson · September 23, 2026 11:00 am
Op-Eds Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing Arie Blitz · September 22, 2026 9:00 am
Op-Eds Organ donation saves lives. The lies are going to get people killed Larry Bucshon · September 21, 2026 11:00 am
Op-Eds Your next cancer scan shouldn’t depend on Moscow’s permission John Czwartacki · September 21, 2026 9:00 am
Op-Eds Trump’s drug price plan targets foreign freeloaders — but shoots American innovators Wayne Winegarden · September 21, 2026 8:00 am
Op-Eds Insurers want you to hate drugmakers so you won’t notice who’s actually robbing you Anne Pritchett · September 20, 2026 9:00 am
Op-Eds
